ReShape Lifesciences Inc. (RSLS)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

1001 CALLE AMANECER SAN CLEMENTE, CA 92673

Obalon Therapeutics, Inc. is a San Diego-based company focused on developing and commercializing novel technologies for weight loss.

Data as of 2021-09-19 13:07:26 -0400
Market Cap47.843 Million Shares Outstanding15.842 Million Avg 30-day Volume1.272 Million
P/E Ratio-4.36766 Dividend Yield EPS-1.32
Price/Sales13.17 Debt to Equity2.06 EBITDA-9.23 Million
Price to Book Value0.8232 Forward PE-1.21 Enterprise Value10.616 Million
Total Cash40.163 Million Current Debt60.496 Million Gross Profit2.218 Million
BETA0.0 52-week High/Low32.31 / 2.16 Next Earnings Date2021-11-11 Price to Cash FLow (P/CF) -12.0144
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from RSLS instead.

View recent insider trading info

Funds Holding RSLS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RSLS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

30 Thousand total shares from 2 transactions

Open Market Sells (S)

542.9 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

STANKOVICH THOMAS CHIEF FINANCIAL OFFICER

  • Officer
32,613 2021-08-30 4

BLACKFORD GARY

  • Director
253,429 2021-07-22 2

GLADNEY DAN W

  • Director
283,922 2021-07-22 2

MINOCHERHOMJEE ARDA PHD

  • Director
253,429 2021-07-22 2

MCDOUGAL LORI COURTNEY

  • Director
253,429 2021-07-22 2

BANDY BARTON P. PRESIDENT AND CEO

  • Officer
  • Director
891,512 2021-07-22 2

ARMISTICE CAPITAL, LLC

BOYD STEVEN

  • 10% Owner
No longer subject to file 2021-06-28 3

DITTAMORE RAYMOND V

0 2020-09-16 0

HOWE LESLEY H

0 2020-09-16 0

KAMDAR KIM P.

0 2020-09-16 0

FISHER DOUGLAS

0 2020-09-16 0

STEVENSON SHARON

0 2020-09-16 0

PLOVANIC WILLIAM J.

0 2020-09-16 0

RASDAL ANDREW P PRESIDENT, CEO & EXEC CHAIRMAN

0 2020-06-23 0

HUSSAINY NOOSHIN CHIEF FINANCIAL OFFICER

0 2020-06-23 0

BRISTER MARK CHIEF TECHNOLOGY OFFICER

0 2020-01-24 0

VANDENBERG AMY CHIEF CLINICAL & REG OFFICER

0 2020-01-24 0

MACDONALD ROBERT J CHIEF RETAIL OFFICER

0 2020-01-24 0

DOMAIN PARTERS VII L P

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

  • 10% Owner
813,433 2019-08-06 0

INTERWEST PARTNERS X LP

INTERWEST MANAGEMENT PARTNERS X, LLC

KLIMAN GILBERT H

ORONSKY ARNOLD L

DESAI KEVAL

NASR KHALED

  • 10% Owner
No longer subject to file 2019-08-06 0

MOATAZEDI DAVID

83,619 2019-07-23 0

HUANG KELLY PRES & CHIEF EXECUTIVE OFFICER

0 2019-01-02 0

YOUNG DONALD R VP OF QUALITY ASSURANCE

0 2019-01-02 0

DRAKE NEIL VP RESEARCH AND DEVELOPMENT

0 2019-01-02 0

MONDORE ROBERT H JR VP OF OPERATIONS

0 2019-01-02 0

SCHMIDT DAINA VICE PRESIDENT OF MARKETING

0 2018-10-08 0

MOATAZEDI DAVID

MOATAZEDI DAVID

5,494 2018-08-23 0

WOOD TODD MICHAEL VICE PRESIDENT OF SALES

5,494 2018-08-23 0

SHACKNAI JONAH

0 2018-06-13 0

METZNER LISA VP OF MARKETING

0 2018-01-02 0

NORWOOD MATTHEW VP OF SALES

0 2018-01-02 0

JOHNSON STEVEN ERNEST VP OF OPERATIONS

1,689 2017-10-31 0

MORISEY ERIN VP STRATEGIC PARTNERSHIPS

1,785 2017-04-30 0

DP VII ASSOCIATES LP

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

  • 10% Owner
49,570 2016-10-12 0

INTERWEST PARTNERS X LP

INTERWEST MANAGEMENT PARTNERS X, LLC

GIANOS PHILIP T

HOLMES W STEPHEN

KLIMAN GILBERT H

ORONSKY ARNOLD L

DESAI KEVAL

NASR KHALED

  • 10% Owner
2,453,338 2016-10-12 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

GLADNEY DAN W - Director

2021-09-17 18:37:24 -0400 2021-09-10 S 200,000 $2.99 d 283,922 direct

BANDY BARTON P. - Director - Officer PRESIDENT AND CEO

2021-09-17 19:07:03 -0400 2021-09-10 S 294,494 $2.89 d 891,512 direct

STANKOVICH THOMAS - Officer CHIEF FINANCIAL OFFICER

2021-09-17 18:51:57 -0400 2021-09-10 S 48,366 $2.89 d 357,991 direct

STANKOVICH THOMAS - Officer CHIEF FINANCIAL OFFICER

2021-08-31 16:31:05 -0400 2021-08-30 P 15,000 $3.43 a 32,613 direct 1.497 -8.6826 1.497 2 -8.6826 6

STANKOVICH THOMAS - Officer CHIEF FINANCIAL OFFICER

2021-08-24 08:59:19 -0400 2021-08-20 P 15,000 $3.22 a 17,613 direct 0.9524 9.8413 9.8413 6 -1.2698 3

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
OBALON THERAPEUTICS INC OBLN 2021-06-14 22:15:03 UTC -86.6569 86.6969 10000
OBALON THERAPEUTICS INC OBLN 2021-06-14 21:45:02 UTC -86.6569 86.6969 10000
OBALON THERAPEUTICS INC OBLN 2021-06-14 21:15:03 UTC -86.6569 86.6969 10000
OBALON THERAPEUTICS INC OBLN 2021-06-14 20:45:03 UTC -86.6569 86.6969 10000
OBALON THERAPEUTICS INC OBLN 2021-06-14 20:15:03 UTC -86.6569 86.6969 10000
OBALON THERAPEUTICS INC OBLN 2021-06-14 19:45:03 UTC -86.6569 86.6969 10000
OBALON THERAPEUTICS INC OBLN 2021-06-14 19:15:03 UTC -86.6569 86.6969 10000
OBALON THERAPEUTICS INC OBLN 2021-06-14 18:45:02 UTC -86.6569 86.6969 6000
OBALON THERAPEUTICS INC OBLN 2021-06-14 18:15:03 UTC -86.6569 86.6969 6000
OBALON THERAPEUTICS INC OBLN 2021-06-14 17:45:03 UTC -86.6569 86.6969 6000
OBALON THERAPEUTICS INC OBLN 2021-06-14 17:15:03 UTC -86.6569 86.6969 6000
OBALON THERAPEUTICS INC OBLN 2021-06-14 16:45:02 UTC -86.6569 86.6969 6000
OBALON THERAPEUTICS INC OBLN 2021-06-14 16:15:03 UTC -86.6569 86.6969 6000
OBALON THERAPEUTICS INC OBLN 2021-06-14 15:45:03 UTC -86.6569 86.6969 6000
OBALON THERAPEUTICS INC OBLN 2021-06-14 15:15:03 UTC -86.6569 86.6969 6000
OBALON THERAPEUTICS INC OBLN 2021-06-14 14:45:03 UTC -86.6569 86.6969 6000
OBALON THERAPEUTICS INC OBLN 2021-06-14 14:15:02 UTC -86.6569 86.6969 4000
OBALON THERAPEUTICS INC OBLN 2021-06-14 13:45:03 UTC -86.6569 86.6969 4000
OBALON THERAPEUTICS INC OBLN 2021-06-14 13:15:03 UTC -86.6569 86.6969 4000
OBALON THERAPEUTICS INC OBLN 2021-06-11 22:15:03 UTC -86.6569 86.6969 10000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund RSLS -966.0 shares, $-4830.0 2021-06-30 N-PORT

Elevate your investments